[发明专利]刺山柑提取物及其制备方法与应用无效
| 申请号: | 200810203382.2 | 申请日: | 2008-11-26 |
| 公开(公告)号: | CN101406497A | 公开(公告)日: | 2009-04-15 |
| 发明(设计)人: | 王长虹;王峥涛;杨涛;程雪梅;周吉燕 | 申请(专利权)人: | 上海中医药大学;上海中药标准化研究中心 |
| 主分类号: | A61K36/185 | 分类号: | A61K36/185;A61K31/7068;A61P19/02;A61P29/00;A61K131/00 |
| 代理公司: | 上海新天专利代理有限公司 | 代理人: | 王 巍 |
| 地址: | 201210上*** | 国省代码: | 上海;31 |
| 权利要求书: | 查看更多 | 说明书: | 查看更多 |
| 摘要: | |||
| 搜索关键词: | 刺山柑 提取物 及其 制备 方法 应用 | ||
1、一种刺山柑提取物,其特征在于该刺山柑提取物包括提取物1、2和3;所述提取物1含有以下30种化合物:化合物1:刺山柑碱A、化合物2:刺山柑酸A、化合物3:刺山柑碱B、化合物4:刺山柑碱C、化合物5:刺山柑碱D、化合物6:对羟基苯甲酸、化合物7:原儿茶酸、化合物8:香草酸、化合物9:原儿醛、化合物10:丁香酸、化合物11:3,4-二羟基苯甲酸、化合物12:反式丁烯二酸、化合物13:乙二酸、化合物14:5-羟甲基糠醛、化合物15:5-羟甲基糠酸、化合物16:2-糠酸、化合物17:二氢-4羟基-5-羟甲基-2(3H)呋喃酮、化合物18:7-hydroxy-2-oxoindolin-3-ylacetic acid、化合物19:尿嘧啶、化合物20:L-内消旋肌醇、化合物21:尿苷、化合物22:山萘酚芸香苷、化合物23:β-胡萝卜苷-6′-硬脂酸酯、化合物24:corchoionoside C、化合物25:spionoside B、化合物26:白花菜苷、化合物27:β-谷甾醇、化合物28:β-胡萝卜苷、化合物29:芦丁、化合物30:吲哚-3-甲醛;
它们的结构式如下:
上述30种化合物的特征波谱数据:
编
名称 波谱数据
号
1 刺山柑碱A 1H-NMR(DMSO-d6,500MHz)δ(ppm):11.34bar(COOH),
9.34(1H,s,CHO),7.13(1H,d,J=3.8Hz,H-8),6.29(1H,
d,J=3.9Hz,H-9),5.64(1H,m,H-5),5.40m(1H,s,
NH),3.08(1H,dd,J=9.2Hz,17.0Hz,H-4a),2.63(1H,
dd,J=6.6Hz,17.0Hz,H-4b);13C-NMR(CD3OD,125MHz)
δ(ppm):179.0(C-11),175.2(C-12),175.1(C-3),125.8(C-8),
144.9(C-10),131.3(C-7),109.7(C-9),54.8(C-1),54.7(C-5),
37.3(C-4);
2 刺山柑酸 1H-NMR(DMSO,500MHz)δ(ppm):7.93(1H,s,H-2),
2.31(3H,s,CH3);13C-NMR(CD3OD,125MHz)δ(ppm):
170.6(COOH),152.2(C-4),146.1(C-3),143.2(C-5),
140.7(C-2),14.8(CH3);
3 刺山柑碱B 1H-NMR(DMSO,500MHz)δ(ppm):9.54(1H,s,CHO),
6.98(1H,d,J=4.01Hz),6.21(1H,d,J=3.78Hz),5.84(1H,
q,J=7.24Hz),5.48(1H,d,J=14.13Hz),5.39(1H,d,
J=14.93Hz),1.72(3H,d,J=7.27Hz CH3);13C-NMR
(CD3OD,125MHz)δ(ppm):179.7(C-11),168.1(C-3),
130.8(C-6),120.3(C-9),124.0(C-7),106.5(C-6),63.3(C-1),
53.8(C-4),19.1(C-10);
4 刺山柑碱C 1H-NMR(DMSO,500MHz)δ(ppm):9.46(1H,s,CHO),
6.93(1H,d,J=3.69Hz,H-3),6.03(1H,d,J=3.52Hz,
H-4),4.96(1H,d,J=15.35Hz,H-7a),4.76(1H,d,J=15.29
Hz,H-7b),4.66(1H,d,J=14.01Hz,H-6a),4.34(1H,d,
J=13.58Hz,H-6b),4.34(1H,m,H-5′),4.25(1H,m,H-4′),
3.77(1H,dd,J=2.49,12.29Hz,H-3′a),3.69(1H,dd,J
=3.64.49,11.87Hz,H-3′b),2.27(1H,m,H-6′);13C-NMR
(CD3OD,125MHz)δ(ppm):178.9(C-8),134.6(C-5),
131.2(C-2),124.2(C-4),105.0(C-3),104.1(C-1′),89.7(C-1′),
72.9(C-5′),62.9(C-3′),58.0(C-7),50.3(C-6),44.9(C-6′);
5 刺山柑碱D 1H-NMR(DMSO,500MHz)δ(ppm):9.45(1H,s,CHO),
6.92(1H,d,J=3.80Hz,H-7′),6.01(1H,d,J=3.46Hz,
H-8′),4.82(1H,d,J=15.18Hz,H-1′a),4.74(1H,d,J
=15.67Hz,H-1′b),4.70(2H,d,J=14.37Hz,H-4′a),4.02
(1H,d,J=13.82Hz,H-4′b),4.17(1H,m,H-4),3.88(1H,
s,H-5),3.89(1H,d,J=12.07Hz,H-6a),3.81(1H,d,J=12.07
Hz,H-6b),2.04(1H,dd,J=5.32,12.82Hz,H-3a),1.91
(1H,t,J=12.43Hz,H-3b);13C-NMR(CD3OD,125MHz)
δ(ppm):178.8(C-10′),134.1(C-9′),131.2(C-6′),124.0(C-7′),
104.8(C-8′),95.4(C-2),67.4(C-5),65.1(C-4),64.5(C-6),
57.8(C-1′),52.2(C-4′),35.8(C-3);
6 对羟基苯甲酸 1H-NMR(CD3OD,500MHz)δ(ppm):7.78(2H,d,J=8.8
Hz,H-3,5),6.72(2H,d,J=8.8Hz,H-2,6),为邻位酚
羟基氢信号;13C-NMR(CD3OD,125MHz)δ(ppm):170.4
(C-7),163.6(C-4),133.3(C-2,C-6),123.0(C-1),116.3(C-3,
C-5);
7 原儿茶酸 1H-NMR(CD3OD,500MHz)δ(ppm):7.31(1H,d,J=1.7
Hz,H-2),7.2(1H,dd,J=8.1,1.7Hz,H-6),6.9(1H,d,
J=8.1Hz,H-5);13C-NMR(CD3OD,125MHz)δ(ppm):
170.7(COOH),151.8(C-4),46.3(C-3),124.2(C-6),
123.5(C-1),118.1(C-2),116.1(C-5);
8 香草酸 1H-NMR(CD3COCD3,500MHz)δ(ppm):12.44(1H,br.s,
COOH),9.81(1H,br.s,OH),7.46(1H,dd,J=8.2,1.7
Hz,H-6),7.43(1H,d,J=1.7Hz,H-2),6.77(1H,d,J=8.2
Hz,H-5),3.79(3H,s,OCH3);13C-NMR(CD3COCD3,
125MHz)δ(ppm):167.5(C-1),152.1(C-4),148.1(C-5),
124.9(C-7),122.9(C-2),115.5(C-3),113.5(C-6),56.4
(OCH3);
9 原儿茶醛 1H-NMR(CD3COCD3,500M Hz)δ(ppm):9.67(s,1H),
8.64(2H,br.s,OH),7.24(1H,d,J=1.84Hz,H-2),7.22
(1H,dd,J=8.03,1.86Hz,H-6),6.87(1H,d,J=8.01
Hz,H-5);
10 丁香酸 1H-NMR(500MHz,CD3OD)δ(ppm):7.20(2H,s,H-2,),
3.76(6H,s,OCH3);13C-NMR(CD3OD,125MHz)δ(ppm):
167.5(COOH),148.4(C-3,5),141.6(C-4),121.5(C-1),
108.2(C-2,6),56.7(OCH3);
11 3,4-二羟基苯甲酸 1H-NMR(MeOD,500MHz)δ(ppm):7.37(1H,d,J=2.0
乙酯 HzH-2),7.31(1H,dd,J=2.0,8.3Hz,H-6),6.76(1H,d,
J=8.3Hz,H-5),4.13(2H,q,OCH2),1.19(3H,t,-CH3);
13C-NMR(CD3OD,125MHz)δ(ppm):166.6(C=O),150.7
(C-4),145.6(C-3),123.3(C-1,6),122.9(C-2,1),117.2
(C-5),115.7(C-2),60.8(OCH2),14.6(CH3);
12 富马酸 1H-NMR(CD3OD,500MHz)δ(ppm):6.81(1H,d,J=15.8
Hz,H-2),6.48(1H,d,J=15.8Hz,H-3);13C-NMR(CD3OD,
125MHz)δ(ppm):134.8(C-2,C-3),166.1(C-1,C-4);
13 丁二酸 1H-NMR(CD3OD,500MHz)δ(ppm):2.5(4H,d,J=15.8Hz,
H-2,3);13C-NMR(CD3OD,125MHz)δ(ppm):176.5(C-1,
C-4),30.1(C-2,C-3);
14 5-羟甲基糠醛 1H-NMR(MeOD,400MHz)δ(ppm):11.16(1H,s,COOH),
7.78(1H,d,J=0.82Hz,H-3),7.22(1H,dd,J=3.32,0.36
Hz,H-5),6.62(1H,dd,J=3.33,1.73Hz,H-4);13C-NMR
(MeOD,125MHz)δ(ppm):159.4(C-1′),147.6(C-5),145.9
(C-2),118.6(C-3),112.7(C-4);
15 5-羟甲基糠酸 1H-NMR(CD3OD,500M Hz)δ(ppm):7.06(1H,d,J=3.42
Hz,H-3),6.36(1H,d,J=3.43Hz,H-4),4.47(3H,s,H2);
13C-NMR(CD3OD,125MHz)δ(ppm):162.08(C-2′),160.99
(C-2),45.99(C-5),120.28(C-3),110.51(C-4),57.8(C-5′);
16 2-糠酸 1H-NMR(MeOD,400MHz)δ:11.16(1H,s,COOH),7.78(1H,
d,J=0.82Hz,H-5),7.22(1H,dd,J=3.32,0.36Hz,H-3),
6.62(1H,t,J=3.33,1.73Hz,H-4);13C-NMR(MeOD,
125MHz)δ:159.41(s,C-1′),147.61(s,C-5),145.96(s,C-2),
118.62(s,C-4),112.71(s,C-3);
17 二氢-4羟基-5-羟 1H-NMR(MeOD,500MHz)δ:4.42(1H,m,5-H);4.36(1H,
甲基-2(3H)呋喃酮 t,J=2.2Hz,J=3.5Hz,4-H);3.76(1H,dd,J=12.4Hz,J=3.3Hz
6-H);3.68(1H,dd,J=12.5Hz,J=3.6Hz,6-H);2.91(1H,
dd,J=18Hz,J=6.8Hz,3-H);2.37(1H,dd,J=17.8Hz,
J=2.6Hz,3-H);13C-NMR(MeOD,125MHz)δ:178.9(C-2),
90.5(C-5),69.9(C-4),62.8(C-6),39.4(C-3);
18 7-hydroxy-2-oxoin 1H-NMR(MeOD,500MHz)δ:6.76(1H,t,J=7.67,H-5);
dolin-3-ylacetic 6.72(1H,dd,J=1.1,7.52Hz,H-4);6.66(1H,dd,J=7.69,
acid 1.5Hz,H-6);3.81(1H,dd,J=3.45Hz,6.41Hz,H-3);
2.75(1H,dd,J=16.44,J=3.46Hz,H-11);2.66(1H,dd,
J=16.44,J=6.57Hz,H-11);13C-NMR(MeOD,125MHz)δ:
175.9(C-11),172.0(C-2),145.8(C-7),126.8(C-8),124.6(C-5),
123.5(C-9),121.0(C-4),115.8(C-6),44.0(C-3),34.4(C-10);
19 尿嘧啶 1H-NMR(DMSO d6,500MHz)δ:13.11(1H,s),12.43(1H,
s),7.59(1H,d,J=7.56Hz),5.88(1H,d,J=7.57Hz)。
13C-NMR(DMSO-d6,125MHz)δ:165.9(C-4),153.3(C-2),
101.4(C-5),142.2(C-6)。1H-NMR上的质子信号δH13.11(1H,
s),12.43(1H,s)为活泼质子的信号,δH 7.59(1H,d,
J=7.5H7),5.40(1H,d,J=7.5Hz)为烯质子信号。13C-NMR
谱显示4个碳信号:165.9,153.3,142.2,101.4分别归属
为不饱和酰胺、脲基和双键的碳信号;
20 内消旋肌醇 13C-NMR(DMSO,400MHz)δC:74.3,72.4,72.2,71.1,
都是连氧碳,δC:72.4,71.1两个碳信号峰较高,说明它们
分别为两个碳信号,化合物应为六元环醇。
1H-NMR(DMSOO,400MHz):δ4.52(1H,d,J=3.72Hz)
δ4.46(1H,d,J=4.19Hz),δ4.44(2H,d,J=3.07Hz),δ4.32(2H,
d,J=5.43Hz),δ3.70(1H,d,J=2.68Hz),δ3.37(1H,dd,
J=2.68.9.34Hz),δ3.11(2H,m),2.90(1H,td,J=9.1,4.07
Hz)从它们的偶合常数看,有一个氢处在e键,其它五个氢
都处于a键;
21 尿苷 1H-NMR(DMSO d6,400MHz)δ:7.98(1H,d,J=8.1Hz,
H-6),5.89(1H,d,J=4.6Hz,H-1′),为糖端基氢信号,因
偶合常数为4.6,表明为α构型,5.69(1H,d,J=8.1,H=8.1Hz,
H-5),3.7~4.2,均为糖上的氢信号。13C-NMR(DMSO-d6,
400MHz)δ:166.5(C-4),152.8(C-2),143.0(C-6),91.0(C-5),
为尿嘧啶的碳信号,102.9为糖端基碳信号,另外的δ86.6,
76.0,71.6,62.6均为糖的碳信号,为五碳糖;
22 山萘酚3-O-芸香苷 1H-NMR(DMSO-d,500MHz)δ:12.56(5OH),10.80(1H,
br s,OH),10.09(1H,br s,OH),7.98(2H,d,J=8.6Hz,
IH-2′,6′),6.87(2H,d,J=8.6Hz,H-3′,5′),6.41(1H,s,
H-8),6.20(1H,s,H-6),5.31(1H,d,J=7.3Hz,H-1″,
ofglucose),4.38(1H,brs,H-rhamnose),0.99(3H,d,J=6.1Hz,
rha-CH3);13C-NMR(DMSO-d,125MHz)δ:177.3(C-4),
164.1(C-7),161.2(C-5),159.8(C-4′),156.8(C-9),156.4(C-2),
133.1(C-3),130.8(C-2′,6′),120.9(C-1′),115.0(C-3′,5′),
103.9(C-10),101.3(C-1″),100.7(C-1″′),98.7(C-6),93.7(C-8),
76.3(C-3″),75.7(C-5″),74.1(C-2″),71.8(C-4″′),70.6(C-3″′),
70.3(C-4″),69.9(C-2″′),68.2(C-5″′),66.8(C-6″),17.7(C-6″′);
23 β-胡萝卜苷-6′-硬 1H-NMR(CDCl3,500MHz)δ:0.65(3H,s,C18-H),0.80-0.98
脂酸酯 (m,CH3),1.25(bra,CH2),1.47-2.00(CH2和CH),2.34(2H,
t,J=7.5Hz,CH2COO),3.36(1H,m,C3-H),3.51-4.37(m,
糖上的氢),5.34(1H,m,C6-H)。13C-NMR(CDCl3,125MHz)
δ:174.2,140.4,122.1,101.3,79.8,76.2,73.8,73.4,
70.5,63.6,56.8,56.2,50.2,45.9,42.4,39.8,38.9,37.3,
36.7,36.2,34.3,33.9,31.9,31.9,29.7-29.8,29.5,29.34,
29.34,29.3,29.2,28.3,26.3,25.0,24.32,23.1,22.7,
21.1,19.8,19.05,18.80,14.10,11.98,11.87;
24 6,9-Dihydroxy-4, 1H-NMR(MeOD-d6,500MHz)δ:5.78(1H,s,H-5),5.70(2H,
7-megastigmadien- m,H-6,7),4.22(1H,dq,J=6.4,4.4Hz,H-9),2.41(1H,
3-onel d,J=16.8Hz,H-a),2.06(1H,d,J=16.9Hz,H-2β),1.82
(1H,d,J=1.2Hz,H-13),1.14(3H,d,J=6.5Hz,H-10),
0.94(3H,s,H-11),0.91(3H,s,H-12)。13C-NMRδ:201.5(C-3),
167.7(C-5),137.3(C-7),130.4(C-7),130.3(C-8),127.4(C-4),
80.3(C-6),69.0(C-9),51.1(C-2),42.7(C-1),24.8(C-12),
24.1(C-11),23.8(C-4),19.8(C-13);
25 spionoside B 1H-NMR(DMSO-d6,500MHz)δ:6.26(1H,d,J=15.26Hz,
H-7),5.94(1H,dd,J=15.25,6.11Hz,H-8),4.75(OH),
4.48(1H,dq,J=6.27,6.36Hz,H-9),4.14(1H,d,J=7.64
Hz,H-1′),3.75(2H,dd,J=7.32,2.49Hz,H-11a),3.49(1H,
d,J=7.39Hz,H-11b),3.63(1H,m,H-6′a),3.38(1H,m,
H-6′b),2.9~3.1(4H,m,H-2′,3′,4′,5′),2.27(d,J=17.47
Hz,H-4a),2.71(d,J=17.2Hz,H-4b),2.67(dd,J=16.78,
1.54Hz,H-2a),2.22(d,J=17.59Hz,H-2b),1.22(d,J=6.49
Hz,H-10),1.07(3H,s,H-13),0.85(3H,s,H-12)。
13C-NMR(DMSO,125MHz)δ:208.1(C-3),134.9(C-8),
127.6(C-7),99.8(C-1′),85.6(C-5),80.8(C-6),77.1(C-5′),
76.9(C-3′),76.5(C-11),73.4(C-2′),71.7(C-9),70.2(C-4′),
61.1(C-6′),52.9(C-4),47.7(C-1),51.8(C-2),22.2(C-10),
15.2(C-12),18.9(C-13);
26 白花菜苷 1H-NMR(DMSO d6,500MHz)δ:5.47(1H,d,J=5.86Hz,
H-8),5.11(1H,d,J=4.77Hz,H-8),5.02(1H,d,J=5.25
Hz,H-8),4.75(1H,d,J=9.79Hz,H-8),4.72(1H,t,
J=5.56Hz,H-8),3.68(1H,dd,J=11.16,5.29Hz,H-8),
3.19(1H,m,H-8),3.17(1H,d,J=4.98Hz,H-8),3.063.17(2H,
m,H-8),2.23(3H,s,H)。13C-NMR(DMSO,125MHz)δ:
154.2(C-1),82.0(C-1′),81.1(C-5′),78.1(C-2′),72.8(C-3′),
70.0(C-4′),61.1(C-6′),18.2(C-2);
27 β-谷甾醇 略
28 β-胡萝卜苷 略
29 芦丁 略
30 1H-indole-3-carbal- 1H-NMR(DMSO-d6,500MHz)δ:7.09~7.15(2H,overlap,
dehyde 5,6-H),7.41(1H,d,J=7.7Hz,7-H),8.05(1H,d,J=2.9
Hz-H),8.09(1H,d,J=7.3Hz,4-H),9.94(1H,s,10-H),
11.02(1H,bar,N-H);13C-NMR(DMSO-d6,125MHz)8:
111.6(C-7),118.7(C-3),120.8(C-9),121.6(C-4),123.1(C-5),
124.1(C-6),136.6(C-2),136.9(C-8),183.9(C-10)。
该专利技术资料仅供研究查看技术是否侵权等信息,商用须获得专利权人授权。该专利全部权利属于上海中医药大学;上海中药标准化研究中心,未经上海中医药大学;上海中药标准化研究中心许可,擅自商用是侵权行为。如果您想购买此专利、获得商业授权和技术合作,请联系【客服】
本文链接:http://www.vipzhuanli.com/pat/books/200810203382.2/1.html,转载请声明来源钻瓜专利网。





